Imidazo[1,2-b]pyridazine as privileged scaffold in medicinal chemistry: An extensive review

Eur J Med Chem. 2021 Dec 15:226:113867. doi: 10.1016/j.ejmech.2021.113867. Epub 2021 Sep 23.

Abstract

Imidazo[1,2-b]pyridazine scaffold represents an important class of heterocyclic nucleus which provides various bioactives molecules. Among them, the successful kinase inhibitor ponatinib led to a resurgence of interest in exploring new imidazo[1,2-b]pyridazine-containing derivatives for their putative therapeutic applications in medicine. This present review intends to provide a state-of-the-art of this framework in medicinal chemistry from 1966 to nowadays, unveiling different aspects of its structure-activity relationships (SAR). This extensive literature surveil may guide medicinal chemists for the quest of novel imidazo[1,2-b]pyridazine compounds with enhanced pharmacokinetics profile and efficiency.

Keywords: Anti-inflammatory; Antibacterial; Anticancer; Antiparasitic; Antiviral; Biological activities; Imidazo[1,2-b]pyridazine; Metabolic disorders; Radiotracers; Sleeping disorders; Structure-activity relationship; Thymic enhancers.

Publication types

  • Review

MeSH terms

  • Anti-Infective Agents / chemistry
  • Anti-Infective Agents / pharmacology*
  • Anti-Inflammatory Agents / chemistry
  • Anti-Inflammatory Agents / pharmacology*
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Chemistry, Pharmaceutical
  • Humans
  • Molecular Structure
  • Pyridazines / chemical synthesis
  • Pyridazines / chemistry
  • Pyridazines / pharmacology*

Substances

  • Anti-Infective Agents
  • Anti-Inflammatory Agents
  • Antineoplastic Agents
  • Pyridazines
  • imidazo(1,2-b)pyridazine